• Gender: Male
• Age: 38
• Designation: Fresh/Entry Level
• Highest Education Level: Doctrate
• Notice Period: 30  Days
• Work Experience: 9.5 Year(s)

Education

PhD in Chemistry From King Abdulaziz University, Saudi Arabia in 2015 with GPA 4.58/5.0

Masters of Pharmacy From Lalitha College of Pharmacy, Osmania University, Hyderabad in 2011 with 82%

Bachelor of Pharmacy From Sri Indu Institute of Pharmacy, JNTU, Hyderabad in 2009 with 74%

Work Experience

Fresher 

Research Associate- Formulation R&D
Nov 2010 to Sep 2011
Company Profile: Manufacturer of Bulk drug intermediates. 
Job Profile:
Responsible for the development of generic and super generic New Drug Delivery Systems; identification of drug candidates, FTO analyses, design of non-infringing formulations with patentable attributes.
Developing formulation approaches for selected product candidates, factoring in technical, regulatory, and intellectual property considerations as per cGMP requirements.
Ensuring Timely completion of new product development activities according to the latest regulatory requirements for ANDA (An Abbreviated New Drug Application) submissions.
Providing technical leadership in all aspects of product development on assigned project, for example preformulation; developing stable and bioequivalent formulations; developing manufacturing processes and overseeing all ANDA and registration batch manufacturing.
Managing scale-up, process development, validation and commercial launch activities on assigned projects

Honors And Awards:
Distinguished Scholar to win Doctoral Fellowship from King Abdulaziz University, Jeddah
Won Post-graduation Fellowship to pursue M.Pharmacy from GATE-UGC, India.
Declared as College Topper at Lalitha College of Pharmacy, India.
Recipient of Under-graduation Fellowship to pursue B.Pharmacy by AICTE, NewDelhi, India.
Won First Prize in National level poster presentation NEOZION by CBIT, India.
Conferred with Certificate of Appreciation for active participation and as best volunteer in International conferences - FIP, APA Boston society, USA.

Presentations:
Chitosan based atorvastat in nanocrystals: Effect of cationic charge on particle size, formulation
stability and in-vivo efficacy” in 3rd International conference, organized by Future University, New
Cairo, Egypt. [2015] – Oral Presentation.

Systemic delivery systems of biodegradable polymers” in 2nd International conference, organized by
Dubai pharmacy college, Dubai, UAE. [2014] – Poster Presentation.

Nanocrystals in drug delivery and therapeutics” International conference, organized by Medical
University of Graz, Graz, Austria. [2013] – Oral Presentation.

Pro-liposomal drug delivery approach and advances” National level conference, organised by 71st FIP,
HICC Novatel, India. [2010]- Poster presentation.

Review on mechanisms in targeting colon drug delivery National level conference, by 61st IPC,
Ahmadabad, India. [2009] - Poster presentation

Bulk Drug opportunities and challenges in India National level conference, organized by CMR college
of Pharmacy, India. [2008] - Oral presentation.

Publications:
PhD:
El-Helw, A. M., Sobahi, T. R., & Abdelaal, M. Y. (2015). Chitosan based atorvastat in nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy. International journal of nanomedicine, 10, 321. http://dx.doi.org/10.2147/IJN.S77731

Ahmed, O. A. A.,  Banjar, Z. M., Afouna, M. I., & Zidan, A. S. (2015). Quality by Design Coupled with Near Infrared in Formulation of Transdermal Glimepiride Liposomal Films. Journal of pharmaceutical sciences, 104 (6), 2062-2075. http://onlinelibrary.wiley.com/doi/10.1002/jps.24448/epdf

Sobahi, T. R., El-Helw, A. M., & Abdelaal, M. Y. (2014). Development and validation of a RPHPLC method for assay of Atorvastatin and its application in dissolution studies on thermosensitive hydrogel-based nanocrystals. Tropical Journal of Pharmaceutical Research, 13(10), 1681-1687. http://dx.doi.org/10.4314/tjpr.v13i10.16

Khalid M Hosny, Seham, and Kurakula, M., Electro Spun- Nanofibrous Mats: A Modern Wound Dressing
Matrix with a Potential of Drug Delivery and Therapeutics-Journal of Engineered Fiber and Fabrics 10(4), 179-193. http://www.jeffjournal.org/papers/Volume10/V10I4(19)%20M.%20Kurakula.pdf

Tarek A Ahmed. Co-delivery of Atorvastatin Nanocrystals in PLGA based In situ Gel for AntiHyperlipidemic Efficacy – Current Drug Delivery- Accepted.

Kurakula, M., Osama AA Ahmed, Tarek A Ahmed, Usama Fahmy. Solid Lipid Nanoparticles for Transdermal
delivery of Avanafil: Optimization, Formulation, In-vitro and Ex-vivo Studies- Journal of Lipo some Research Accepted.

Masters:
Venkatesh, M., (2013). Self-nano emulsifying drug delivery systems (SNEDDS) for oral
delivery of atorvastatin–formulation and bioavailability studies. -Journal of Drug Delivery and Therapeutics, 3(3), 131-140. http://jddtonline.info/index.php/jddt/article/view/517/301

Vanitasagar, S., Srinivas, C., Subhashini, N. J. P., & Kurakula, M., (2012). Solid dispersion-a comparative study on the dissolution rate of Acelofenac. -International Journal of Pharmacy and Pharmaceutical Sciences, 4(3), 274-278. http://www.ijppsjournal.com/Vol4Issue3/4013.pdf

Kumar, R., & Chowdary, P. (2012). Piroxicam proliposomal gel-A novel approach for
topical delivery. - Journal of Pharmacy Research, 5(3), 1755-1763.
http://jpronline.info/index.php/jpr/article/viewFile/12355/6326

Srinivas, C., Kasturi, N., & Diwan, P. V. (2012). Formulation and evaluation of
prednisolone proliposomal gel for effective topical pharmacotherapy - International Journal for
Pharmaceutical Sciences and Drug Research, 4(1), 35-43. http://www.ijpsdr.com/pdf/vol4-issue1/7.pdf

Mohd, A. B., Rao, P., & Diwan, P. V. (2011). Estimation of Piroxicam in Proliposomal
Formulation Using RP HPLC Method - International Journal of Chemical and Analytical science, 2(9),
1193-1196
http://ijcas.info/index.php/ijca/article/viewArticle/9381

Mohd, A. B., Samhuidrom Rao, P., & Diwan, P. V. (2011). Estimation of prednisolone in
proliposomal formulation using RP-HPLC method. -International Journal of research in Pharma and
Biomedical Sciences, 2 (4), 1663-1669

Professional Membership:
FIP World congress member under ‘Young Pharmacist Group’-31947.
Indian Pharmaceutical Association ‘Life Time Membership’ -AP/HYD/LM/0547.
Registered Pharmacist under Andhra Pradesh Pharmacy Council of INDIA- A68523.

Profile:
Dynamic and result oriented Formulation Scientist with Doctor of Philosophy (PhD), Chemistry, from
King Abdulaziz University, Saudi Arabia with expertise in design and development of Polymer or
Nanotechnology based novel drug delivery systems.
Researched and provided formulation support for commercialization of nanotechnology based dosage formlike polymeric nanocrystals (top- down or Bottom-up], nanoparticles, nanosuspensions; or liposomes; solid lipid nanoparticles for delivery via oral; transdermal; intramuscular or intravascular delivery routes.
Studied the role of biomaterials; biodegradable polymers of natural or synthetic origin with pH or
thermosensitive responsiveness and their application in developing drug delivery systems, as novel
stabilisers in nanotherapeutics or as gelling polymers in In-situ gel (ISG) system intended for long term pharmacotherapies.
Experience in statically modelling, including Box behnken, Draper-Lin small composite design, Design of Experiments (DoE) or Quality by design (QbD) applications that are widely used in parameter estimation or to understand the response surface methodology to develop optimized drug formulation.
Strong skills in development and validation of in-house analytical methods for qualitative and
quantitative estimation of drug within formulation using chromatographic techniques like HPLC. To
evaluate its competence application in studying the cumulative drug release in-vitro dissolution and
pharmacokinetics.
Applied sound scientific theory to experimental work in operating several polymer characterisation tools
like SEM /TEM, DSC, XRD, GTA, FTIR, and worked on various unit operations including protein freeze/ thaw, ultra-filtration, formulation, , analyzing data, writing technical reports and assessments.
Executed lab and pilot scale experimentation, especially in animal models development, small animal handling, feeding, blood collection with hyperlipidemia induction experiments for pre-clinical drug evaluation and development.
Pioneered in molecular biology techniques majorly analysis of lipids like Total cholesterol, Triglycerides, lipoproteins like HDL and LDL in serum, using regular enzymatic techniques like Elisa.
In-depth knowledge and skills in cell cultures, estimation by flow cytometry, immunofluorescence based imaging studies.
Excellent communicator and presents development activities, findings and evaluates and resolves complex technical issues related to new concepts, products, equipment or processes for development of new pharmaceutical applications.

Future Goals

Growth